Insights
Search Results
Press Releases
11.17.25
Wilson Sonsini Goodrich & Rosati Elects 12 Attorneys to Partner
PALO ALTO, CA (November 17, 2025)—Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, today announced the election of 12 new partners from within the firm’s attorney ranks. The promotions will take effect on February 1, 2026.
Alerts
8.19.25
UKIPO Decides Patentability of Computer Games in the UK Involving Real-World Player Interactions
A recent decision issued by the UK Intellectual Property Office (UKIPO) concerning a patent application filed by a game developer company Bandai Namco Entertainment Inc. (Bandai Namco) serves as a useful example for informing patent strategies on gameplay mechanics in the UK. Bandai Namco, as some may be aware, is the creator of games such as Pac-Man™ and Elden Ring™.
Client Highlights
7.02.25
Firm Advises Matterworks on IP and Patent Matters Related to Series A Financing
On June 3, 2025, Matterworks, Inc., the category-defining pioneer unlocking unstructured molecular data for predictive biology, announced a new Series A financing. The round was led by Lewis & Clark Partners and OMX Ventures and joined by Pillar VC, Germin8 Ventures, Intermountain Ventures, and Tarsadia, among others. Matterworks will use the Series A proceeds to grow its model as a service (MaaS) business and expand its machine learning and scientific operations. For example, Matterworks' Large Spectral Models (LSMs) productize self-supervised machine intelligence for direct machine interpretation of molecular-omic data. The company’s PyxisTMproduct, released in 2024, is the first generative AI for complete untargeted molecular annotation, unlocking new data modalities for understanding and predicting complex biological outcomes.
Client Highlights
3.25.25
Firm Advises Sonocharge on IP Matters Related to $23.5 Million Funding Round
On January 22, 2025, Sonocharge Energy, an innovative tech company enabling the world's batteries to last longer, charge faster, and be safer, announced a $23.5 million financing round led by ClimateTech’s venture capital firm Cycle Capital, with participation from Honda, current investor Khosla Ventures, Temasek, and non-dilutive funding partners. Wilson Sonsini Goodrich & Rosati has advised Sonocharge on IP matters related to its financing rounds since 2024.
Client Highlights
11.26.24
Firm Advises Kinematics on IP Matters Related to Acquisition of P4Q
On November 20, 2024, Kinematics, a global leader in intelligent motion control, announced it has signed a definitive agreement to acquire P4Q, an industry leader in electronics for solar tracker controllers, industrial automation, sensors, and cloud-based monitoring. This strategic acquisition will enable Kinematics to better serve the world’s leading solar tracker original equipment manufacturers (OEMs) with expanded global reach and a unified motion control solution that simplifies installation, commissioning, and maintenance.
By integrating P4Q’s capabilities into the Kinematics portfolio of actuators, sensors, and controllers, the combination will offer unprecedented energy efficiency, reliability, and precision to improve utility-scale solar production worldwide. The unified offering will support new and existing projects alike, providing solar tracker customers with the most advanced motion control systems for future installations, while also giving asset owners a path toward upgrading outdated systems. The combined technologies will also become the industry’s most reliable, field-tested, and bankable motion control solution.
The Wilson Sonsini team advising Kinematics on IP matters since 2017 and also on this transaction included Peter Eng and Hin Au.
By integrating P4Q’s capabilities into the Kinematics portfolio of actuators, sensors, and controllers, the combination will offer unprecedented energy efficiency, reliability, and precision to improve utility-scale solar production worldwide. The unified offering will support new and existing projects alike, providing solar tracker customers with the most advanced motion control systems for future installations, while also giving asset owners a path toward upgrading outdated systems. The combined technologies will also become the industry’s most reliable, field-tested, and bankable motion control solution.
The Wilson Sonsini team advising Kinematics on IP matters since 2017 and also on this transaction included Peter Eng and Hin Au.
Client Highlights
10.02.24
Wilson Sonsini Advises Pure Lithium on Asset Acquisition of Dimien
On October 1, 2024, Pure Lithium Corporation, a disruptive Boston-based vertically integrated lithium metal battery technology company, announced the acquisition of all the assets of Dimien Inc., a private U.S. vanadium cathode materials company. Pure Lithium acquired Dimien’s intellectual property, know-how, and manufacturing equipment. Dimien's experienced team will also join the company. Wilson Sonsini Goodrich & Rosati advised Pure Lithium on the transaction.
Newsletters
6.10.24
The Life Sciences Report – June 2024
This latest edition features articles on biotech client Siolta Therapeutics, the use of safety and efficacy findings to extend drug exclusivity periods, life sciences venture financings for clients in 2023, and updated USPTO guidance for determining non-obviousness. The newsletter also includes details on the recent LaunchBio NextGen VC Forum in San Francisco, the firm’s Patents and Innovations Learning Library for in-house IP counsel, the latest episodes of the LaunchBio/Wilson Sonsini NextGen VC Podcast focused on life sciences investing, and the firm’s sponsorship of the National Inventors Hall of Fame Induction Ceremony, as well as select life sciences client highlights.
Client Highlights
3.14.24
Wilson Sonsini Advises Pure Lithium on $15 Million Series A
On March 14, 2024, Pure Lithium, a disruptive Boston-based lithium metal battery technology company, announced the completion of a $15 million Series A financing led by Oxy Low Carbon Ventures, a subsidiary of Occidental. Wilson Sonsini Goodrich & Rosati advised Pure Lithium on the transaction. The capital infusion will accelerate Pure Lithium's development and commercialization efforts.
Alerts
2.09.24
Bipartisan Legislation Seeks to Clarify Which Inventions Are Patent Eligible
The U.S. patent system is based upon a quid pro quo balance that incentivizes innovation via a time-limited patent exclusivity, while encouraging the dissemination of new ideas for public benefit and use upon expiration of the patented innovation. However, for some innovative technologies, such as personalized medicine, diagnostics, and artificial intelligence (AI), case law developed within the past decade has made obtaining patent protection increasingly difficult. This has led to a lack of clarity and incentive for some innovators to develop technologies that may not be eligible for patent protection.1
Newsletters
1.04.24
The Life Sciences Report – January 2024
This issue features articles on the firm’s Business Advisory Practice supporting Nervosave Therapeutics’ U.S. expansion; the USPTO’s forthcoming guidance on AI innovation protection; option pool sizes for life sciences companies; life sciences venture financings for clients in 2H 2022 and 1H 2023; and Congress’s attempts to improve medical diagnostics patent eligibility. It also includes a client interview with SonoThera CEO Kenneth Greenberg, an article on DOJ’s incentives for life sciences companies to self-disclose misconduct, and a Q&A with Ed Shenkan on decreasing risk from medical device concept to commercialization, as well as details on recent life sciences-focused NextGen VC Forums hosted by Wilson Sonsini and LaunchBio, the 28th annual Phoenix Conference and 2023 Life Sciences Investment Forum, and select life sciences client highlights.
Client Highlights
9.30.21
Firm Advises Activ Surgical on IP Matters Related to $45 Million Series B Financing
On September 30, 2021, Activ Surgical, a digital surgery pioneer, announced that it has raised $45 million in a Series B financing round. The financing was led by Cota Capital and included participation from new investors, including BAM Funds, Magnetar Capital, MINT Venture Partners, Castor Ventures, Dream One Vision, and NVIDIA, as well as existing investors DNS Capital, Tao Capital Partners, LRVHealth, Rising Tide VC, GreatPoint Ventures (GPV), and ARTIS Ventures.
Client Highlights
7.16.21
Wilson Sonsini Represents Aurora in Merger with Reinvent Technology Partners Y
On July 15, 2021, Aurora, the self-driving technology company, has entered into a definitive business combination agreement with Reinvent Technology Partners Y (Reinvent), a special purpose acquisition company (SPAC). Upon closing of the proposed transaction, the combined company will be named Aurora Innovation, Inc. and be publicly traded, with its common stock expected to be listed on Nasdaq with the ticker symbol "AUR." Wilson Sonsini Goodrich & Rosati is representing Aurora in the transaction.